CClinicalTrials.gg
Active, not recruitingNCT06810063Updated Mar 27, 2026

Feasibility and Reliability of the Melbourne Assessment-2 (MA-2) for Telehealth

An observational study in Cerebral Palsy and Hemiplegic Cerebral Palsy, sponsored by Ohio State University. Active, not recruiting at 1 site in United States. Open to participants aged 2 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Ohio State University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
35
Ages
2 Years to 10 Years
Sex
All
01

Study summary

The goals of this study:

  1. Determine if a play based test of arm and hand movements is valid and reliable when conducted through telehealth for children with hemiplegic cerebral palsy.
  2. Measure differences in parent, provider and child engagement when an assessment is conducted in-person compared to via telehealth.
  3. Rate caregivers' overall impressions of procedures when an assessment is conducted in-person compared to telehealth.

Participants will attend two visits, one in person and one through telehealth. During each visit, the child will play with common toys. The sessions will be video recorded and scored using two standardized assessments, the Melbourne Assessment-2 (MA-2) and the Assisting Hand Assessment.

Read the detailed description

After a child has a stroke, noticeable and lifelong developmental concerns emerge. One side of the body is typically much weaker, often impacting the arm/hand more than the leg/foot, so we focus on the arm/hand. The weakness is like adults with stroke, but in children, stroke impairs play, reaching for/holding toys, communication gestures, and whole-body movement. Because of this, most children with pediatric stroke will receive physical and/or occupational therapy throughout childhood. Traditionally, rehabilitation occurs with the child, caregiver and therapist meeting in person at clinics, homes, or schools. However, telehealth rehabilitation, where the therapist and patient meet virtually through a computer or tablet, has emerged a sustainable and accessible alternative. Telehealth also has the potential to improve access to quality treatments, improve health outcomes and reduce healthcare costs. One problem with telehealth rehabilitation is that few assessments have been validated for use in telehealth. In adults with stroke, researchers have identified several assessments for that work well via telehealth. Similarly, in children with one specific brain disease, researchers found that the results of one commonly used gross motor test are similar when delivered via telehealth compared to in-person. Unfortunately, there is no studied arm/hand assessment for children with stroke. This makes it hard to measure if telehealth rehabilitation changes arm/hand function. This proposal will test two playful arm/hand assessments via telehealth. Investigators will test 35 children (2-10 years old) twice (once in-person and once via telehealth) with the same assessment and compare the results. Investigators will use two well-established assessments, the Melbourne Assessment-2 and the Assisting Hand Assessment. Both assessments will be recorded- via camera (in-person) and secure videoconferencing (telehealth). Those recordings will then be scored by a therapist trained in the Melbourne Assessment and Assisting Hand Assessment. Investigators will compare the results of both assessments to see if the scores match.

02

Conditions studied

  • Cerebral Palsy
  • Hemiplegic Cerebral Palsy

Browse trials for

Keywords

  • Assessment
  • Telehealth
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's planned enrollment of 35 is below the median of 63 across 455 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Ohio State University is the lead sponsor of 640 studies on the registry; 144 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 45 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children, ages 2-10 years old with hemiplegic Cerebral palsy

Inclusion criteria

  • ages 2-10 years old
  • hemiplegic cerebral palsy
  • able to attend an in-person visit in the research lab OR live within 60 miles of the research lab
  • able to attend a telehealth session with personal device

Exclusion criteria

Exclusion Criteria:

  • child or caregiver does not speak English
  • unable to attend one in person visit and one telehealth visit within 1 month
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
35 participants (estimated)
Patient registry
No

Groups and cohorts

  • In-person vs. telehealth assessment

    Participants will be randomly assigned to in-person visit first or telehealth visit first. Both groups will complete both visits. Each visit requires about 20 minutes.

    Other: Assessment only, no intervention

Interventions

  • OtherAssessment only, no intervention

    Participants in this study complete two visits to test the agreement of telehealth and in person assessments of arm and hand movement.

06

What researchers measure

Primary outcomes

  1. Melbourne Assessment-2

    Upper Extremity assessment, range 0-100, higher score indicates better outcomes.

    Time frame: 1 month

  2. Assisting Hand Assessment

    Upper extremity assessment, range 0-100, higher score indicates better outcomes.

    Time frame: 1 month

Secondary outcomes

  1. Acceptability Intervention Measure

    Evaluate acceptability of telehealth assessment, 4 questions rated on 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Reported as proportion of items rated at or above 4/5

    Time frame: immediately after telehealth visit

  2. Intervention Appropriateness Measure

    Evaluate appropriateness of telehealth assessment, 4 questions rated on 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Reported as proportion of items rated at or above 4/5

    Time frame: immediately after telehealth visit

  3. Feasibility of Intervention Measure

    Evaluate feasibility of telehealth assessment, 4 questions rated on 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Reported as proportion of items rated at or above 4/5

    Time frame: immediately after telehealth visit

07

Study locations

1 site
  • The Ohio State University Wexner Medical Center
    Columbus, Ohio 43210, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06810063
Lead sponsor
Ohio State University
Responsible party
Jill Heathcock (Professor, Division of Physical Therapy, Ohio State University) — Principal investigator
First posted
Feb 5, 2025
Start date
Sep 18, 2023
Primary completion
Nov 24, 2025
Completion
May 2026 (estimated)
Last update
Mar 27, 2026

Study contacts

Jill Heathcock, PhD
principal investigator · Ohio State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion